Ophthalmic Sutures Market Analysis

Based on coating, the ophthalmic sutures market from coated sutures segment is likely to grow at over 6% CAGR through 2023 and 2032, driven by the long-lasting properties of coated sutures and their ability to cause minimal tissue reaction. They also reduce friction for ease of tissue movement and offer enhanced suture flexibility. The coating material also allows for the suture to be coated with antibiotics that makes it more infection-resistant. Existing antibiotics used by industry players are depicting sufficient effectiveness against bacterial resistance. Subsequently, coated sutures are being regarded as promising tools to combat surgical site infections.
 

In terms of end-use, the ophthalmic sutures market is classified into ambulatory surgical centers, hospitals, and others. The ambulatory surgical centers segment valuation is poised to reach nearly USD 425 million by 2032, owing to the rising number of ambulatory surgical centers and surging patient preference for minimally invasive surgical procedures. As per a survey, the rate of surgeries at ASCs is growing consistently in countries such as the U.S., where these facilities are increasingly focusing on improving and speeding up postoperative surgery recovery and offering high-quality, affordable services.
 

Asia Pacific ophthalmic sutures market is estimated to grow at over 9% CAGR over 2023 and 2032. APAC holds the highest diabetes-related disease burden in the world. The International Diabetes Federation estimates that the total diabetes cases in South-East Asia are likely to reach 113 million by 2030. In China, which is regarded as the nation with the highest number of diabetes cases globally, over 140 million people are suffering from eye diseases. This presents a sizable growth opportunity for industry players that have a presence in the region. U.S. ophthalmic sutures industry is expected to observe a 5.5% CAGR through 2032 owing to growing prevalence of eye diseases in the U.S.